MedPath

Effect of parathyroid hormone therapy for mediation related osteonecrosis of the jaw.

Not Applicable
Conditions
Medication related osteonecrosis of the jaw
Registration Number
JPRN-UMIN000024896
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with malignant cancer in the bone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spontaneous sequestration separation 6 months after starting drug therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath